100% Rapid rescreening for quality assurance in a quality control program in a public health cytologic laboratory

Acta Cytologica

Volumn 49, Issue 6, 2005, Pages 639-643

  Mattosinho De Castro Ferraz, Maria Da Gloria ^a,b   Dall'Agnol, Miria ^a   Di Loreto, Celso ^a   Pirani, Wiliam M ^a   Utagawa, Maria Lúcia ^a   Pereira, Sonia Maria Miranda ^a   Sakai, Yuriko Ito ^a   Feres, Camilo Lelis ^a   Shih, Lai W S ^a   Yamamoto, Luzia Setuko ^a   Rodrigues, Rosemeire O L ^a   Shirata, Neuza Kasumi ^a   Longatto Filho, Adhemar ^c  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

Cervical cancer; Health care quality assurance; Mass screening; Papanicolaou smear; Quality control; Rapid rescreening

Indexed keywords

ARTICLE; BETHESDA SYSTEM; CONSENSUS; CONTINUING EDUCATION; CYTODIAGNOSIS; EARLY DIAGNOSIS; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING TEST; SMEAR; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 27944491896     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326252     Document Type: Article

References (26)

1. Waggoner SS: Cervical cancer. Lancet 2003;361:2217-2225
2. Sasieni P: Cancer screening for medical oncologists: Importance of quality control and audit. Ann Oncol 2002;13:199-204
3. Miller AB: Quality assurance in screening strategies. Vírus Res 2002;89:295-299
4. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-819
5. Franco EF, Duarte-Franco E, Ferenczy A: Prospects for controlling cervical cancer at the turn of the century. Salud Publica Mex 2003;45:S367-S375
6. Schneider V, Henry MR, Jimenez-Ayala M, Turnbull LS, Wright TC: Cervical cancer screening, screening errors and reporting. Acta Cytol 2001;45:493-498
7. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG: Enthusiasm for cancer screening in the United States. JAMA 2004; 291:71-78
8. Lemay C, Meisels A: 100% rapid (partial) rescreening for quality assurance. Acta Cytol 1999;43:86-88
9. van Ballegooijen M, van den Akker-van Marle E, Patnick J, Lynge E, Arbyn M, Anttila A, Ronco G, Dik J, Habbema F: Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 2000;36:2177-2188
10. Centers for Disease Control and Prevention: Medicare, Medicaid, and CLIA programs: Laboratory requirements relating to quality systems and certain personnel qualifications: Final rule. Fed Reg 2003;68:3639-3714
11. Melamed MR, Flechinger BJ. Reevaluation of quality assurance in the cytology laboratory (edit). Acta Cytol 1992;36:461-465
12. Tabbaro SO, Sidway MK: Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure. Diagn Cytopathol 1997;14:191-192
13. Bleggi-Torres LF, Werner B, Totsugui J, Collaço LM, Araujo SR, Huculak M, Boza EJ, Fisher RM, De Laat L, Sobbania LC, Raggio A: Cervical cancer screening program of Parana: Cost-effective model in a developing country. Diagn Cytopathol 2003;29:49-54
14. Dudding N: Rapid rescreening of cervical smears: An improved method of quality control. Cytopathology 1995;6:95-99
15. Arbyn M, Schenck U, Ellison E, Hanselaar A: Metaanalysis of the accuracy of rapid prescreening relative to full screening of Pap smears. Cancer 2003;99:9-16
16. Dudding N: Rapid rescreen: A viable alternative to 1:10? Diagn Cytopathol 2001;24:219-221
17. Solomon D, Davey D, Kurman R, Moriaty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright W Jr, Young N: The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
18. Mody DR, Davey DD, Branca M, Raab SS, Schenck UG, Stanley MW, Wright RG, Arbyn M, Beccati D, Bishop JW, Collaço LM, Cramer S, Fitzgerald P, Heirich J, Jhala NC, Montanari G, Kapila K, Narychk, Suprun HZ: Quality assurance and risk reduction guidelines. Acta Cytol 2000;44:496-507
19. Tan KB, Chang SAE, Soh VCH, Thamboo TP, Nilsson B, Chan NHL: Quality indices in a cervicovaginal cytology service: Before and after laboratory accreditation. Arch Pathol Lab Med 2004;128:303-307
20. Renshaw AA, Davey DD, Birdson GG, Walsh M, Slyer PE, Mody DR, Colgan TJ: Precision in gynecologic cytologic interpretation: A study from the College of American Pathologists interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med 2003;127:1413-1420
21. Van der Graaf Y, Vooijs GP: False negative rate in cervical cytology. J Clin Pathol 1987;40:438-442
22. Hanselaar AG: Criteria for organized cervical screening programs: Special emphasis on the Netherlands program. Acta Cytol 2002;46:619-629
23. Renshaw AA: Rescreening in cervical cytology for quality control: When bad data is worse than no data or what works, what doesn't, and why. Clin Lab Med 2003;23:695-708
24. O'Sullivan JP, Chapan PA, Jenkins L, Smith R: Characteristics of high grade cervical smears likely to be missed on rapid rescreening. Acta Cytol 2000;44:37-40
25. Brown AD, Garber AM: Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA 1999;281: 347-353
26. Dudding N, Hewer EM, Lancucki L, Rice S: Rapid screening: A comparative study. Cytopathology 2001;12:235-248